Targeting oxidative stress-NLRP3-apoptotic-steroidogenic axis in doxorubicin-induced testicular toxicity: protective efficacy of ferulic acid niosomes.
FA-NIO shows potential in reducing doxorubicin-induced testicular damage in rats, but human studies are needed to confirm its clinical relevance.
Where it sits
this study against the rest of the zenagamtide corpusSummary and findings
This study evaluated the protective effects of ferulic acid-loaded niosomes (FA-NIO) against doxorubicin-induced testicular toxicity in rats. The study measured serum reproductive hormones, oxidative stress indices, and gene expression related to apoptosis and steroidogenesis. FA-NIO treatment reduced histopathological damage and normalized hormone levels more effectively than free ferulic acid.
Abstract
Doxorubicin (DOX) is a commonly prescribed chemotherapeutic agent whose clinical application is limited by its toxicity to rapidly dividing organs, particularly the testes.This study explored the protective potential of ferulic acid-loaded niosomes (FA-NIO) against DOX-induced testicular dysfunction in rats and elucidated the underlying molecular mechanisms. Forty male rats were allocated into four groups: Group 1 was given saline, Group 2 was given DOX, Group 3 was given DOX + free FA, and Group 4 was given DOX + FA-NIO. Serum reproductive hormone levels, testicular oxidative stress indices, and the expression of genes and proteins relevant to NLRP3 inflammasome signaling, apoptosis (Bax and Bcl-2), and steroidogenesis (StAR, CYP11A1, and 3β-HSD) were assessed, along with histopathological changes in the testicular tissue. DOX administration significantly increased MDA (malondialdehyde) while suppressing antioxidant defences, accompanied by hormonal imbalance, severe histopathological damage, upregulation of Bax, NLRP3, and IL-1β, downregulation of Bcl-2, and inhibition of steroidogenic gene expression. On the other hand, these changes were partially mitigated in the DOX + free FA group. Notably, FA-NIO treatment reduced histopathological damage, normalised reproductive hormone levels, markedly increased steroidogenesis-related gene expression, suppressed apoptotic and inflammasome-related gene expression, and greatly restored antioxidant capacity. Compared with DOX + free FA, FA-NIO consistently demonstrated greater protective efficacy. In summary, FA-NIO targets oxidative stress-mediated apoptosis, attenuates NLRP3 inflammasome-related signaling, and restores steroidogenic function, thereby successfully attenuating DOX-induced testicular toxicity. These results suggest that FA-NIO may represent a promising nanotherapeutic strategy for attenuating chemotherapy-induced reproductive toxicity in a rat model.
Background
Doxorubicin is a widely used chemotherapeutic agent known for its efficacy but also for its toxicity to rapidly dividing tissues, such as the testes. This study investigates whether ferulic acid-loaded niosomes can mitigate the testicular toxicity induced by doxorubicin. Understanding these protective mechanisms is crucial for developing strategies to reduce the side effects of chemotherapy on reproductive health.
Methods
The study involved 40 male rats divided into four groups: saline control, doxorubicin (DOX) only, DOX with free ferulic acid, and DOX with ferulic acid-loaded niosomes (FA-NIO). The primary outcomes included serum reproductive hormone levels, oxidative stress indices, and gene expression related to NLRP3 inflammasome signaling, apoptosis, and steroidogenesis. Histopathological changes in testicular tissue were also assessed.
Results
FA-NIO treatment significantly reduced histopathological damage and normalized reproductive hormone levels compared to the DOX group. It also increased the expression of genes related to steroidogenesis and suppressed those related to apoptosis and inflammasome signaling. The FA-NIO group showed greater protective efficacy than the group treated with free ferulic acid.
Interpretation
The study suggests that FA-NIO offers a more effective protective strategy against doxorubicin-induced testicular toxicity than free ferulic acid in rats. While the findings are promising, the clinical significance remains uncertain due to the lack of human data. The study's reliance on a rat model and absence of detailed quantitative results limit its applicability to human clinical practice.
Key findings
- 40 male rats allocated into four groups.
- DOX significantly increased MDA levels and suppressed antioxidant defenses.
- FA-NIO treatment reduced histopathological damage and normalized hormone levels.
- FA-NIO increased steroidogenesis-related gene expression.
- FA-NIO suppressed apoptotic and inflammasome-related gene expression.
Limitations
- rat model only, no human data
- no quantitative results or p-values reported
- short-term study duration
- potential differences in human and rat testicular physiology